The authors recommend a combination of a beta - lactam / beta - lactamase inhibitor or a third G cephalosporin plus a macrolide in most SCAP patients , and to empirically cover PES ( P . aeruginosa , extended spectrum beta - lactamase producing Enterobacteriaceae , methicillin - resistant S . aureus ) pathogens when at least two specific risk factors are present